SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-311251
Filing Date
2011-11-14
Accepted
2011-11-14 16:57:31
Documents
12
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d231251d10q.htm 10-Q 694132
2 EMPLOYMENT AGREEMENT WITH MARK SUMERAY d231251dex101.htm EX-10.1 60612
3 AMENDEMENT NO.1 TO EMPLOYMENT AGREEMENT d231251dex102.htm EX-10.2 6445
4 CERTIFICATION OF MARC D. BEER, CEO FILED PURSUANT TO SECTION 302 d231251dex311.htm EX-31.1 10193
5 CERTIFICATION OF MARK J. FITZPATRICK, CFO FILED PURSUANT TO SECTION 302 d231251dex312.htm EX-31.2 10541
6 CERTIFICATION OF MARC D. BEER, CEO FILED PURSUANT TO SECTION 906 d231251dex321.htm EX-32.1 4391
7 CERTIFICATION OF MARK J. FITZPATRICK, CFO FILED PURSUANT TO SECTION 906 d231251dex322.htm EX-32.2 4426
  Complete submission text file 0001193125-11-311251.txt   2107902

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT aegr-20110930.xml EX-101.INS 223439
9 XBRL TAXONOMY EXTENSION SCHEMA aegr-20110930.xsd EX-101.SCH 9875
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aegr-20110930_cal.xml EX-101.CAL 34815
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE aegr-20110930_lab.xml EX-101.LAB 121514
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aegr-20110930_pre.xml EX-101.PRE 73919
Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34921 | Film No.: 111203880
SIC: 2834 Pharmaceutical Preparations